This industry profile provides a five-year forecast for Canada’s Pharmaceutical Products Industry.
Canada’s Pharmaceutical Products Industry: Canadian Industrial Profile Winter2009
Canada’s Pharmaceutical Products Industry: Canadian Industrial Profile Winter2009
Industry Economic Analysis
$550.00
- U.S. Recession—Although health-care spending is defensive, uninsured and unemployed people will spend less on drugs. With half of production destined for the U.S., the industry will be affected.
- Price Controls—Medications that are still under patent protection are subject to price controls in Canada. This has contributed to surging exports to the U.S.— but has also limited price and profit growth.
- Aging Population—People spend more on pharmaceutical products as they age. Thus, as the average age of the population increases, so does per capita spending on drugs.
